← Back to Clinical Trials
Recruiting NCT05846282

NCT05846282 Students Rising Above: Offsetting the Health and Mental Health Costs of Resilience

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05846282
Status Recruiting
Phase
Sponsor University of California, Los Angeles
Condition Internalizing Mental Health Symptoms
Study Type INTERVENTIONAL
Enrollment 504 participants
Start Date 2023-01-09
Primary Completion 2027-06

Eligibility & Interventions

Sex All sexes
Min Age 13 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
STRIVEStudy Skills

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 504 participants in total. It began in 2023-01-09 with a primary completion date of 2027-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Students who 'strive' to rise above significant stressors to achieve academic success are considered 'resilient'. However, youths' resilience in one domain (i.e. academic) can come at a cost in other domains including physical and mental health morbidities that are under-identified and under-treated. Previous research suggests that individuals from populations experiencing documented health disparities who exhibit a "striving persistent behavioral style" in the face of stress evince later health morbidities. Ironically, the same self-regulatory skills that promote academic achievement amid chronic stress can also result in physiological dysregulation that harms health and mental health. Self-regulatory processes that involve emotion suppression, experiential avoidance, and unmodulated perseverance can culminate in allostatic load which fuels health disparities and internalizing symptoms of depression and anxiety. The proposed mechanistic trial will utilize mindfulness training to permit examination of questions about the causal role of emotion regulation strategies linked to the striving persistent behavioral style in driving mental health and health morbidities among individuals from populations experiencing documented health disparities. The proposed Project STRIVE (STudents RIsing aboVE) will identify students who are academically resilient in the face of stress and will offer a tailored mindfulness intervention targeting self-regulation processes as a putative mechanism to interrupt the links between the striving persistent behavioral style and negative health outcomes. Investigators propose a multisite randomized trial randomizing 504 high achieving Black, Latinx, or Asian America/Pacific Islander students in 18 schools to receive a mindfulness intervention or an attention control condition focused on study skills. The study will: (1) test the effects of the STRIVE intervention on putative self-regulation mechanisms (emotion suppression, experiential avoidance, and unmodulated perseverance) among identified students, (2) test the effects of the STRIVE intervention on health and mental health outcomes at 12-month post-treatment, including biomarkers of allostatic load (cortisol, blood pressure, body-mass-index, waist/hip/neck circumference), health complaints, and internalizing symptoms, and (3) examine the mechanistic model linking striving persistent behavioral style and health outcomes within the STRIVE trial.

Eligibility Criteria

Inclusion Criteria: * Enrolled in 10th or 11th grade at a participating high school * Black, Latinx, Asian American/Pacific Islander, or American Indian/Alaskan Native * High achieving (e.g., GPA above 3.5 and/or in the top 20% of their grade, enrolled in advanced classes such as AP/IB/honors classes) Exclusion Criteria: * Intellectual Disability

Contact & Investigator

Central Contact

Anna S Lau, PhD

✉ alau@psych.ucla.edu

📞 (310) 206-5363

Principal Investigator

Anna S Lau, PhD

PRINCIPAL INVESTIGATOR

University of California, Los Angeles

Frequently Asked Questions

Who can join the NCT05846282 clinical trial?

This trial is open to participants of all sexes, aged 13 Years or older, studying Internalizing Mental Health Symptoms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05846282 currently recruiting?

Yes, NCT05846282 is actively recruiting participants. Contact the research team at alau@psych.ucla.edu for enrollment information.

Where is the NCT05846282 trial being conducted?

This trial is being conducted at Los Angeles, United States.

Who is sponsoring the NCT05846282 clinical trial?

NCT05846282 is sponsored by University of California, Los Angeles. The principal investigator is Anna S Lau, PhD at University of California, Los Angeles. The trial plans to enroll 504 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology